ATM - risk factor breast cancer

This test is available for the following conditions:

  • Conditions > Oncogenetics > Breast and Ovary cancer, hereditary

This product is also part of the following panels:

  • panel hereditary breast/ovarian cancer (BRCA1,BRCA2,ATM,BARD1,BRIP1,CHEK2,PALB2,PTEN, RAD51C,RAD51D)
  • panel hereditary breast/ovarian cancer (BRCA1,BRCA2,ATM,BARD1,BRIP1,CHEK2,PALB2,PTEN, RAD51C,RAD51D)
  • WES comprehensive preconception carrier test ¹
  • WES hereditary cancer (% *)
  • WES Mendelian inherited disorders (% *)
  • WES movement disorders (% *)
  • WES primary immunodeficiencies (% *)

* % of the coding region of this gene has a coverage of >20x. (Without % information : This is a non-coding gene for which coverage statistics could not be determined)

Turnaround time
Complete analysis & Targeted analysis: 3 weeks

Method

  • Sequence analysis of all coding exons and flanking intron-exon boundaries

OMIM: 607585
Performing laboratory: Radboudumc & Maastricht UMC+
Authorized material(s): EDTA blood, FFPE, Isolated DNA




€ 509

Panel

DNA-first hereditary breast cancer

Turnaround time
Urgent (2-3 weeks)
Performing laboratory
Radboudumc & Maastricht UMC+
€ 0

DNA-first hereditary breast cancer



€ 0

DNA-first hereditary breast cancer

This test is available for the following conditions:

  • Conditions > Oncogenetics > Breast and Ovary cancer, hereditary

Turnaround time
Urgent (2-3 weeks)

Method

  • Sequence analysis of all coding exons and flanking intron-exon boundaries
  • CNV analysis of all genes based on NGS

Performing laboratory: Radboudumc & Maastricht UMC+
Authorized material(s): EDTA blood




€ 0
Gene

ATM - risk factor breast cancer

Turnaround time
Complete analysis & Targeted analysis: 3 weeks
Performing laboratory
Radboudumc & Maastricht UMC+
€ 509

ATM - risk factor breast cancer



€ 509
Gene

BARD1 - risk factor breast cancer

Turnaround time
Complete analysis & Targeted analysis: 3 weeks
Performing laboratory
Radboudumc & Maastricht UMC+
€ 509

BARD1 - risk factor breast cancer



€ 509

BARD1 - risk factor breast cancer

This test is available for the following conditions:

  • Conditions > Oncogenetics > Breast and Ovary cancer, hereditary

Turnaround time
Complete analysis & Targeted analysis: 3 weeks

Method

  • Sequence analysis of all coding exons and flanking intron-exon boundaries

OMIM: 601593
Performing laboratory: Radboudumc & Maastricht UMC+
Authorized material(s): EDTA blood, FFPE, Isolated DNA




€ 509
Gene

BRCA1 - hereditary breast cancer and/or ovarian cancer (only familial mutation testing)

Turnaround time
Complete analysis & Targeted analysis: 3 weeks
Performing laboratory
Radboudumc & Maastricht UMC+
€ 320

BRCA1 - hereditary breast cancer and/or ovarian cancer (only familial mutation testing)



€ 320

BRCA1 - hereditary breast cancer and/or ovarian cancer (only familial mutation testing)

This test is available for the following conditions:

  • Conditions > Oncogenetics > Breast and Ovary cancer, hereditary

This product is also part of the following panels:

  • panel hereditary breast/ovarian cancer (BRCA1,BRCA2,ATM,BARD1,BRIP1,CHEK2,PALB2,PTEN, RAD51C,RAD51D)
  • panel hereditary breast/ovarian cancer (BRCA1,BRCA2,ATM,BARD1,BRIP1,CHEK2,PALB2,PTEN, RAD51C,RAD51D)
  • WES comprehensive preconception carrier test ¹
  • WES hereditary cancer (% *)
  • WES inherited bone marrow failure and/or predisposition to hematological malignancies (% *)
  • WES Mendelian inherited disorders (% *)

* % of the coding region of this gene has a coverage of >20x. (Without % information : This is a non-coding gene for which coverage statistics could not be determined)

Turnaround time
Complete analysis & Targeted analysis: 3 weeks

Method

  • Sequence analysis of selected exons and flanking intron-exon boundaries
Remarks
Analysis of a known familial mutation only (screening).

OMIM: 113705
Performing laboratory: Radboudumc & Maastricht UMC+
Authorized material(s): EDTA blood, FFPE, Isolated DNA




€ 320
Gene

BRCA2 - hereditary breast cancer and/or ovarian cancer (only familial mutation testing)

Turnaround time
Complete analysis & Targeted analysis: 3 weeks
Performing laboratory
Radboudumc & Maastricht UMC+
€ 320

BRCA2 - hereditary breast cancer and/or ovarian cancer (only familial mutation testing)



€ 320

BRCA2 - hereditary breast cancer and/or ovarian cancer (only familial mutation testing)

This test is available for the following conditions:

  • Conditions > Oncogenetics > Breast and Ovary cancer, hereditary

This product is also part of the following panels:

  • panel hereditary breast/ovarian cancer (BRCA1,BRCA2,ATM,BARD1,BRIP1,CHEK2,PALB2,PTEN, RAD51C,RAD51D)
  • panel hereditary breast/ovarian cancer (BRCA1,BRCA2,ATM,BARD1,BRIP1,CHEK2,PALB2,PTEN, RAD51C,RAD51D)
  • WES comprehensive preconception carrier test ¹
  • WES hereditary cancer (% *)
  • WES inherited bone marrow failure and/or predisposition to hematological malignancies (% *)
  • WES Mendelian inherited disorders (% *)
  • WES sonic hedgehog medulloblastoma (% *)

* % of the coding region of this gene has a coverage of >20x. (Without % information : This is a non-coding gene for which coverage statistics could not be determined)

Turnaround time
Complete analysis & Targeted analysis: 3 weeks

Method

  • Sequence analysis of all coding exons and flanking intron-exon boundaries
  • Deletion/duplication analysis (MLPA)
Remarks
Analysis of a known familial mutation only (screening).
MLPA analysis only upon request.

OMIM: 600185
Performing laboratory: Radboudumc & Maastricht UMC+
Authorized material(s): EDTA blood, FFPE, Isolated DNA




€ 320
Gene

BRIP1 - hereditary ovarian cancer (only familial mutation testing)

Turnaround time
Complete analysis & Targeted analysis: 3 weeks
Performing laboratory
Radboudumc & Maastricht UMC+
€ 509

BRIP1 - hereditary ovarian cancer (only familial mutation testing)



€ 509

BRIP1 - hereditary ovarian cancer (only familial mutation testing)

This test is available for the following conditions:

  • Conditions > Oncogenetics > Breast and Ovary cancer, hereditary

Turnaround time
Complete analysis & Targeted analysis: 3 weeks

Method

  • Sequence analysis of selected exons and flanking intron-exon boundaries

OMIM: 605882
Performing laboratory: Radboudumc & Maastricht UMC+
Authorized material(s): EDTA blood, FFPE, Isolated DNA




€ 509
Gene

CHEK2 - risk factor breast cancer

Turnaround time
Complete analysis & Targeted analysis: 3 weeks
Performing laboratory
Radboudumc & Maastricht UMC+
€ 509

CHEK2 - risk factor breast cancer



€ 509

CHEK2 - risk factor breast cancer

This test is available for the following conditions:

  • Conditions > Oncogenetics > Breast and Ovary cancer, hereditary

This product is also part of the following panels:

  • panel hereditary breast/ovarian cancer (BRCA1,BRCA2,ATM,BARD1,BRIP1,CHEK2,PALB2,PTEN, RAD51C,RAD51D)
  • panel hereditary breast/ovarian cancer (BRCA1,BRCA2,ATM,BARD1,BRIP1,CHEK2,PALB2,PTEN, RAD51C,RAD51D)
  • WES hereditary cancer (% *)
  • WES Mendelian inherited disorders (% *)

* % of the coding region of this gene has a coverage of >20x. (Without % information : This is a non-coding gene for which coverage statistics could not be determined)

Turnaround time
Complete analysis & Targeted analysis: 3 weeks

Method

  • Sequence analysis of selected exons and flanking intron-exon boundaries

OMIM: 604373
Performing laboratory: Radboudumc & Maastricht UMC+
Authorized material(s): EDTA blood, FFPE, Isolated DNA




€ 509
Gene

PALB2 - hereditary breast cancer

Turnaround time
Complete analysis & Targeted analysis: 3 weeks
Performing laboratory
Radboudumc & Maastricht UMC+
€ 509

PALB2 - hereditary breast cancer



€ 509

PALB2 - hereditary breast cancer

This test is available for the following conditions:

  • Conditions > Oncogenetics > Breast and Ovary cancer, hereditary

This product is also part of the following panels:

  • panel hereditary breast/ovarian cancer (BRCA1,BRCA2,ATM,BARD1,BRIP1,CHEK2,PALB2,PTEN, RAD51C,RAD51D)
  • panel hereditary breast/ovarian cancer (BRCA1,BRCA2,ATM,BARD1,BRIP1,CHEK2,PALB2,PTEN, RAD51C,RAD51D)
  • WES hereditary cancer (% *)
  • WES inherited bone marrow failure and/or predisposition to hematological malignancies (% *)
  • WES Mendelian inherited disorders (% *)
  • WES skin disorders¹ (% *)
  • WES sonic hedgehog medulloblastoma (% *)

* % of the coding region of this gene has a coverage of >20x. (Without % information : This is a non-coding gene for which coverage statistics could not be determined)

Turnaround time
Complete analysis & Targeted analysis: 3 weeks

Method

  • Sequence analysis of all coding exons and flanking intron-exon boundaries

OMIM: 610355
Performing laboratory: Radboudumc & Maastricht UMC+
Authorized material(s): EDTA blood, FFPE, Isolated DNA




€ 509
Gene

RAD51C - hereditary ovarian cancer (only familial mutation testing)

Turnaround time
Complete analysis & Targeted analysis: 3 weeks
Performing laboratory
Radboudumc & Maastricht UMC+
€ 509

RAD51C - hereditary ovarian cancer (only familial mutation testing)



€ 509

RAD51C - hereditary ovarian cancer (only familial mutation testing)

This test is available for the following conditions:

  • Conditions > Oncogenetics > Breast and Ovary cancer, hereditary

Turnaround time
Complete analysis & Targeted analysis: 3 weeks

Method

  • Sequence analysis of all coding exons and flanking intron-exon boundaries
  • Deletion/duplication analysis (MLPA)
Remarks
MLPA analysis only upon request.

OMIM: 613399
Performing laboratory: Radboudumc & Maastricht UMC+
Authorized material(s): EDTA blood, FFPE, Isolated DNA




€ 509
Gene

RAD51D - hereditary ovarian cancer (only familial mutation testing)

Turnaround time
Complete analysis & Targeted analysis: 3 weeks
Performing laboratory
Radboudumc & Maastricht UMC+
€ 509

RAD51D - hereditary ovarian cancer (only familial mutation testing)



€ 509

RAD51D - hereditary ovarian cancer (only familial mutation testing)

This test is available for the following conditions:

  • Conditions > Oncogenetics > Breast and Ovary cancer, hereditary

Turnaround time
Complete analysis & Targeted analysis: 3 weeks

Method

  • Sequence analysis of all coding exons and flanking intron-exon boundaries
  • Deletion/duplication analysis (MLPA)
Remarks
MLPA analysis only upon request.

OMIM: 614291
Performing laboratory: Radboudumc & Maastricht UMC+
Authorized material(s): EDTA blood, FFPE, Isolated DNA




€ 509